טוען...
Recombinant T Cell Receptor Ligand (RTL) Treats Experimental Stroke
BACKGROUND AND PURPOSE: Experimental stroke induces a biphasic effect on the immune response that involves early activation of peripheral leukocytes followed by severe immunodepression and atrophy of spleen and thymus. In tandem, the developing infarct is exacerbated by influx of numerous inflammato...
שמור ב:
| Main Authors: | , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2009
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2704258/ https://ncbi.nlm.nih.gov/pubmed/19443805 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.108.543991 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|